# Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration

> **NCT01570790** · PHASE1,PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 8 (actual)

## Conditions studied

- Combretastatin A4 Phosphate
- Age-related Macular Degeneration
- AMD
- CNV
- Choroidal Neovascularization

## Interventions

- **DRUG:** Combretastatin A-4 phosphate
- **DRUG:** Combretastatin A-4 Phosphate
- **DRUG:** Combretastatin A-4 Phosphate

## Key facts

- **NCT ID:** NCT01570790
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2017-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01570790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01570790, "Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01570790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*